These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15121343

  • 21. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited.
    Harwood AJ.
    Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078
    [Abstract] [Full Text] [Related]

  • 22. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
    Manji HK, Chen G.
    Mol Psychiatry; 2002 Jan; 7 Suppl 1():S46-56. PubMed ID: 11986995
    [Abstract] [Full Text] [Related]

  • 23. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
    Song N, Boku S, Nakagawa S, Kato A, Toda H, Takamura N, Omiya Y, Kitaichi Y, Inoue T, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug 07; 38(2):183-9. PubMed ID: 22484386
    [Abstract] [Full Text] [Related]

  • 24. Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients.
    Silverstone PH, McGrath BM.
    Int Rev Psychiatry; 2009 Aug 07; 21(4):414-23. PubMed ID: 20374155
    [Abstract] [Full Text] [Related]

  • 25. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
    Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF.
    Biol Psychiatry; 2004 Sep 01; 56(5):340-8. PubMed ID: 15336516
    [Abstract] [Full Text] [Related]

  • 26. [Predictors of prophylactic response to lithium].
    Rohayem J, Baylé JF, Richa S.
    Encephale; 2008 Sep 01; 34(4):394-9. PubMed ID: 18922242
    [Abstract] [Full Text] [Related]

  • 27. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
    Jin N, Kovács AD, Sui Z, Dewhurst S, Maggirwar SB.
    Neuropharmacology; 2005 Mar 01; 48(4):576-83. PubMed ID: 15755485
    [Abstract] [Full Text] [Related]

  • 28. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice.
    Umeda K, Suemaru K, Todo N, Egashira N, Mishima K, Iwasaki K, Fujiwara M, Araki H.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):157-62. PubMed ID: 17070517
    [Abstract] [Full Text] [Related]

  • 29. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
    Di Daniel E, Cheng L, Maycox PR, Mudge AW.
    Mol Cell Neurosci; 2006 Dec 28; 32(1-2):27-36. PubMed ID: 16531065
    [Abstract] [Full Text] [Related]

  • 30. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC, Eisch AJ.
    Psychiatr Clin North Am; 2005 Jun 28; 28(2):399-414. PubMed ID: 15826739
    [Abstract] [Full Text] [Related]

  • 31. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
    Kurita M, Nishino S, Ohtomo K, Rai M, Shirakawa H, Mashiko H, Niwa S, Nakahata N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):600-4. PubMed ID: 17258372
    [Abstract] [Full Text] [Related]

  • 32. Search for a common mechanism of mood stabilizers.
    Harwood AJ, Agam G.
    Biochem Pharmacol; 2003 Jul 15; 66(2):179-89. PubMed ID: 12826261
    [Abstract] [Full Text] [Related]

  • 33. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL.
    J Clin Psychiatry; 2005 Jul 15; 66 Suppl 3():12-9. PubMed ID: 15762830
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
    Bazinet RP.
    Biochem Soc Trans; 2009 Oct 15; 37(Pt 5):1104-9. PubMed ID: 19754461
    [Abstract] [Full Text] [Related]

  • 36. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
    Li X, Ketter TA, Frye MA.
    J Affect Disord; 2002 May 15; 69(1-3):1-14. PubMed ID: 12103447
    [Abstract] [Full Text] [Related]

  • 37. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy.
    Manji HK, Chen G, Hsiao JK, Risby ED, Masana MI, Potter WZ.
    J Clin Psychiatry; 1996 May 15; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [On the relevance of protein kinase C to lithium therapy in bipolar disorder].
    Sela B.
    Harefuah; 2004 Jun 15; 143(6):414-6, 462. PubMed ID: 15524097
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.